Coldstream Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-642
| Closed | -$156K | – | 1388 |
|
|
2025
Q1 | $156K | Sell |
642
-220
| -26% | -$53.6K | ﹤0.01% | 1126 |
|
|
2024
Q4 | $283K | Buy |
862
+14
| +2% | +$4.6K | 0.01% | 850 |
|
|
2024
Q3 | $284K | Buy |
848
+20
| +2% | +$6.7K | 0.01% | 865 |
|
|
2024
Q2 | $226K | Sell |
828
-24
| -3% | -$6.56K | 0.01% | 891 |
|
|
2024
Q1 | $295K | Sell |
852
-288
| -25% | -$99.6K | 0.01% | 775 |
|
|
2023
Q4 | $368K | Buy |
1,140
+480
| +73% | +$155K | 0.01% | 628 |
|
|
2023
Q3 | $237K | Sell |
660
-36
| -5% | -$12.9K | 0.01% | 688 |
|
|
2023
Q2 | $264K | Buy |
696
+60
| +9% | +$22.7K | 0.01% | 672 |
|
|
2023
Q1 | $305K | Sell |
636
-4
| -0.6% | -$1.92K | 0.01% | 621 |
|
|
2022
Q4 | $269K | Buy |
+640
| New | +$269K | 0.01% | 651 |
|
|
2022
Q2 | $292K | Buy |
590
+156
| +36% | +$77.2K | 0.01% | 572 |
|
|
2022
Q1 | $244K | Sell |
434
-151
| -26% | -$84.9K | 0.01% | 661 |
|
|
2021
Q4 | $442K | Buy |
+585
| New | +$442K | 0.01% | 460 |
|
|
2020
Q3 | – | Sell |
-657
| Closed | -$296K | – | 310 |
|
|
2020
Q2 | $296K | Sell |
657
-35
| -5% | -$15.8K | 0.03% | 232 |
|
|
2020
Q1 | $242K | Sell |
692
-109
| -14% | -$38.1K | 0.03% | 230 |
|
|
2019
Q4 | $297K | Buy |
801
+3
| +0.4% | +$1.11K | 0.02% | 255 |
|
|
2019
Q3 | $265K | Hold |
798
| – | – | 0.02% | 268 |
|
|
2019
Q2 | $250K | Buy |
798
+25
| +3% | +$7.83K | 0.02% | 269 |
|
|
2019
Q1 | $237K | Buy |
+773
| New | +$237K | 0.02% | 268 |
|
|
2018
Q4 | – | Sell |
-858
| Closed | -$269K | – | 321 |
|
|
2018
Q3 | $269K | Buy |
+858
| New | +$269K | 0.02% | 283 |
|